Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural Bupivacaine Nebulization for Pain After VATS
NCT05282251Recruiting
- Sponsor
- Assiut University
- Start
- May 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Time to first rescue analgesia at 24 hours. Started May 2024; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05282251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05282251.